VEGFA and cervical squamous cell carcinoma: It has also been reported that patients with cervical invasive carcinoma have increased expression of VEGF; while bevacizumab (a VEGF‐targeting monoclonal antibody) is effective against advanced squamous cell carcinoma of the cervix.10